FDA: Fluconazole linked to increased miscarriage risk

April 27, 2016

(HealthDay)—Doctors should use caution when prescribing the antifungal drug fluconazole (Diflucan) during pregnancy because it may raise the risk of miscarriage, the U.S. Food and Drug Administration warns.

The agency said it is evaluating the results of a recent Danish study that suggested a link between fluconazole and miscarriage, along with additional data, and will release final conclusions and recommendations when the review is completed.

Current labeling information suggests that a single 150 mg dose of oral fluconazole to treat is safe to take during . However, the FDA noted that in rare cases higher doses taken during pregnancy (400 to 800 mg a day) had been linked to abnormalities at birth. In the Danish study, most of the fluconazole use appeared to be one or two doses of 150 mg.

"Until the FDA's review is complete and more is understood about this study and other available data, the FDA advises cautious prescribing of oral fluconazole in pregnancy," the agency said in a news release. The agency also noted that the U.S. Centers for Disease Control and Prevention recommends only antifungal creams to treat pregnant women with vaginal yeast infections—even for longer periods than usual if the infections persist or recur.

Explore further: Use of oral antifungal medication during pregnancy, risk of spontaneous abortion

More information: More Information

Related Stories

Use of oral antifungal medication during pregnancy, risk of spontaneous abortion

January 5, 2016
In an analysis of approximately 1.4 million pregnancies in Denmark, use of the oral antifungal medication fluconazole during pregnancy was associated with an increased risk of spontaneous abortion compared with risk among ...

Anti-fungal drug not tied to most birth defects, study says

August 28, 2013
(HealthDay)—Although some reports have shown that high doses of the anti-fungal drug fluconazole (Diflucan) may raise the risk of birth defects, a new Danish review finds that more commonly prescribed lower doses of the ...

Antifungal prophylaxis regimens in liver transplant found equal

December 8, 2014
(HealthDay)—Antifungal prophylaxis is associated with reductions in invasive fungal infections (IFIs) in liver transplant recipients, according to research published in the December issue of the American Journal of Transplantation.

Medication does not lower risk of fungal infection, death among ELBW infants

May 3, 2014
Use of the antifungal medication fluconazole for six weeks for extremely low birth-weight infants did not significantly reduce the risk of death or invasive candidiasis, a serious infection that occurs when candida (a type ...

Managing migraine during pregnancy and lactation

March 30, 2016
According to doctors at Wake Forest Baptist Medical Center, medications and treatments long considered safe to treat pregnant women with migraines may not be.

New skin cancer drug approved by FDA

July 25, 2015
(HealthDay)—A new drug to treat the most common form of skin cancer has been approved by the U.S. Food and Drug Administration.

Recommended for you

Drug overdose epidemic has been growing exponentially for decades

September 20, 2018
Death rates from drug overdoses in the U.S. have been on an exponential growth curve that began at least 15 years before the mid-1990s surge in opioid prescribing, suggesting that overdose death rates may continue along this ...

Anti-cancer drugs may hold key to overcoming antimalarial drug resistance

September 20, 2018
Scientists have found a way to boost the efficacy of the world's most powerful antimalarial drug with the help of chemotherapy medicines, according to new research published in the journal Nature Communications.

Probiotic use may reduce antibiotic prescriptions, researchers say

September 14, 2018
Use of probiotics is linked to reduced need for antibiotic treatment in infants and children, according to a review of studies that probed the benefits of probiotics, say researchers in the U.S., England and the Netherlands.

Recalled blood pressure drugs not linked to increased short term cancer risk

September 12, 2018
Products containing the withdrawn blood pressure drug valsartan are not associated with a markedly increased short term risk of cancer, finds an expedited analysis published by The BMJ today.

Sugar pills relieve pain for chronic pain patients

September 12, 2018
Someday doctors may prescribe sugar pills for certain chronic pain patients based on their brain anatomy and psychology. And the pills will reduce their pain as effectively as any powerful drug on the market, according to ...

A new approach for finding Alzheimer's treatments

September 11, 2018
Considering what little progress has been made finding drugs to treat Alzheimer's disease, Maikel Rheinstädter decided to come at the problem from a totally different angle—perhaps the solution lay not with the peptide ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.